|
Dzhalilzoda S.S.
Prevalence and diagnosis of autosomal dominant polycystic kidney disease
|
№3 / 2024
|
|
Trushkin R.N., Medvedev P.E., Lagoyskaya Yu.A., Fettser D.V., Klementieva T.M.
Morphological features of polycystic kidney in acute renal artery occlusion
|
№2 / 2024
|
|
Vtorenko V.I., Trushkin R.N., Medvedev P.E., Vinogradov V.E., Isaev T.K., Sokolov S.A., Bondarenko S.A., Kolesnikov N.O., Ivanov K.V.
The use of bilateral total transarterial renal embolization for the combined treatment of patients with symptomatic autosomal dominant polycystic kidney disease and end-stage renal disease
|
№3 / 2023
|
|
Trushkin R.N., Medvedev P.E., Isaev T.K., Klementieva T.M., Morozov N.V., Ivanov K.V.
Modern strategies for the treatment of patients with autosomal dominant polycystic kidney disease
|
№4 / 2022
|
|
Z.R. Bashirova, I.M. Osmanov
Association of proteolysis factors with progression of autosomal dominant polycystic kidney disease in children
|
№4 / 2021
|
|
M.S. Ignatova, S.L. Morozov, T.A. Kryganova, D.V. Shentseva, N.F. Nazarova, N.E. Kon'kova, V.V. Dlin
Congenital anomalies of kidney and urinary tract syndrome in children: modern statement
|
№2 / 2013
|
|
Autosomal-dominant polycystic kidney disease: perspectives of treatment
|
№3 / 2011
|
Русский
